Description
FDG & NEURACEQ RADIOPHARMACEUTICALS
First action · last action
2024-03-27 · 2026-05-19
Transactions
7
First transaction's obligation
$317,950
Base + all options value (sum of deltas)
$1,388,338
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-03-27+$317,950= $317,950
- Mod P000012025-02-27+$317,950= $635,900
- Mod P000022025-04-30+$8,910= $644,810
- Mod P000032025-06-17-$191,102= $453,708
- Mod P000042026-02-26+$326,860= $780,568
- Mod P000052026-04-16-$19,220= $761,348
- Mod P000062026-05-19+$0= $761,348
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-03-27 | +$317,950 | $317,950 | FDG & NEURACEQ RADIOPHARMACEUTICALS |
| Mod P00001· EXERCISE AN OPTION | 2025-02-27 | +$317,950 | $635,900 | FDG & NEURACEQ RADIOPHARMACEUTICALS |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-04-30 | +$8,910 | $644,810 | FDG & NEURACEQ RADIOPHARMACEUTICALS |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-06-17 | −$191,102 | $453,708 | FDG & NEURACEQ RADIOPHARMACEUTICALS |
| Mod P00004· EXERCISE AN OPTION | 2026-02-26 | +$326,860 | $780,568 | FDG & NEURACEQ RADIOPHARMACEUTICALS |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-04-16 | −$19,220 | $761,348 | FDG & NEURACEQ RADIOPHARMACEUTICALS |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-05-19 | +$0 | $761,348 | FDG & NEURACEQ RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JV1AHJHGUGG3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0392 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $357,066 | FY2026 |
| 36C25526N0245 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $1,172,834 | FY2026 |
| 36C24226N0463 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $624,017 | FY2026 |
| 36C24226N0388 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $830,796 | FY2026 |
| 36C24226D0040 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C25026P0310 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $347,000 | FY2026 |
Other recipients under 6505 from 244-NETWORK CONTRACT OFFICE 4 (36C244) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24426D0097 | CARDINAL HEALTH 414, LLC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $0 | FY2026 |
| 36C24426N0938 | CARDINAL HEALTH 414, LLC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $650,641 | FY2026 |
| 36C24426N0948 | ERA HEALTH LLC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $29,590 | FY2026 |
| 36C24426P0339 | NUCLEAR DIAGNOSTIC PRODUCTS OF PHILADELPHIA, INC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $126,204 | FY2026 |
| 36C24426N0663 | LUMINEX CORP | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $121,316 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24424P0468_3600_-NONE-_-NONE- · retrieved 2026-09-26.